Theravance Biopharma
potential for patients highly differentiated therapy delivering significant market expansion | Theravance Biopharma
Company
Deck Type
Sector
Industry
Deck date
August 2023
Slide
17 of 35
Related slides by other companies
Kymera
Investor Presentation
August 2023
part summary | Kymera
Dare Bioscience
Investor Presentation
February 2023
overview she toe phosphate vaginal gel is a antibacterial indicated for the treatment of bacterial in female patients years of age and older this marks the first approved product in dar portfolio of potential first in category development candidates first commercial sale anticipated in the | Dare Bioscience
Paysafe
SPAC
December 2020
combined to create growth deliver results highly differentiated at attractive strong | Paysafe
Apollomics
SPAC
September 2022
indications for near term submissions | Apollomics
Other recent decks by Theravance Biopharma
See all presentations (5 decks)
Results
May 2023
Investor Conference
April 2023
Results
February 2023
Investor Conference
November 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights